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ABSTRACT
Total and HLA-DR positive alveolar macrophages were enumerated in the broncho-alveolar
lavage fluids of active pulmonary tuberculosis, inactive pulmonary tuberculosis (treated cases), non-
tuberculous lung disease patients and normal healthy individuals.A significantly increased number
of macrophages was found in the patient groups than the normal individuals: however, there was
no difference in HLA-DR positive cells. Among the different patient groups, smokers had more
macrophages as well as more HLA-DR positive macrophages than non-smokers and normal subjects
Total number of alveolar macrophages of the active tuberculosis non-smoker group was significantly
higher than the inactive tuberculosis non-smoker group and normal individuals.On the contrary,
a slightly decreased number of HLA-DR positive cells was seen in the non-smoker group of active-TB
patients. The present study suggests that infection and smoking induce the accumulation of
macrophages in the lung. The implication of these findings in relation to tuberculosis is discussed.
Introduction
Immunologically active cells lining the alveolar
region of the lung are predominantly alveolar macro-
phages. These cells are mainly involved in elimi-
nating the inhaled irritants and defence against
pathogens. Macrophages appear to be important
for bacterial phagocytosis and killing(1). Further.
these cells are involved in host resistance to M. tuber-
culosis (2,3). These mononuclear phagocytes pro-
duce reactive oxygen intermediates such as super
oxide anion and hydrogen peroxide. These reactive
oxygen intermediates are well known for their micro-
bicidal function. This represents cellular capacity
for microbicidal function and the host defense func-
tion against intracellular pathogens. (4,5,6,7).
The human leukocyte antigen system (HLA) is
divided into Class-l (HLA-A, -B & -C) and Class-II
(HLA-DR, -DP, & -DQ) antigens. The Class-II anti-
gens are known as Ia antigens (immune region
associated antigen) (8).It is well known that acti-
vation of macrophages by pathogens or any other
antigens or lymphokines will increase the expression
of immune region associated Ia antigen and alters
other functions of the macrophages (9,10). It is
well established that these Ia- antigens are responsible
for the immunological functions such as antigen
presentation to T-lymphocytes that leads to T-cell
proliferation and these cells are responsible for
specific cell-mediated immunity(11). The present
study was carried out to enumerate the number of
total alveolar macrophages and I a positive (HLA-DR+)
and Ia negative (HLA-DR-) alveolar macrophages
in active pulmonary tuberculosis, inactive pulmonary
tuberculosis, non-tuberculous lung disease patients
and normal individuals.
Material and Methods
The patients included in this study were suspected
cases of pulmonary tuberculosis, attending Tuber-
culosis Research Centre with respiratory symptoms
and radiographic evidence of lung diseases of varying
duration. All the patients had at least six sputum
smears negative for M. tuberculosis by microscopy.
All sputa were cultured for M. tuberculosis. Based
on the culture results, the patients were classified into
three groups.
(i) Active pulmonary tuberculosis: these patients
had not received any previous antituberculosis
chemotherapy and had grown M. tuberculosis
in one or more sputum specimens in culture
(10 patients).
(ii) Inactive pulmonary tuberculosis: These pati-
ents had had previous antituberculosis chemo-
therapy and presently their sputum showed
culture negativity for M. tuberculosis (10
patients).
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(iii) Non-tuberculous Lung Disease: This group
included patients with lung abscesses. bacte-
rial pneumonia and pulmonary manifestations
of polycythemia vera (eight patients).
(iv) Normal subjects who had normal chest
skiagram and pulmonary functions and were
non-smokers (four individuals).
Fibreoptic Bronchoscopy and Broncho alveolar
lavage (BAL)
An informed written consent was obtained from
each subject. The procedure was done in the morning
after overnight fasting.Atropine 0.6-0.8 mg (i.m.)
and Diazepam 5 mg (i.v) were givenas pre-
medication. The upper airways and trachea were
anesthetized with 4% xylocaine spray. After en-
suring that there was no gag reflex, fibreoptic
bronchoscope was inserted either through the mouth
or the nose. The tip of the broncoscope was wedged
into the third or fourth order bronchus in the affected
lobe and also two other lobes, usually middle lobe
and lingula. Sterile isotonic saline was then infused
in five 20ml aliquots with each aliquot being immedi-
ately aspirated using a suction pressure of 50-100 mm
of water. Each of the three lobes was lavaged with
100 ml saline for a total of 300 ml per subject.The
recovered fluid was pooled and the total volume
measured. The entire bronchoscopy procedure
was done under continuous cardiac and pulse-
oximeter monitoring, and oxygen was supplemented
during and after the procedure(12).
Enumeration of total macrophage population in
the lavage fluid
The total number of macrophages was enumerated
using hemocytometer. The percentage of dead cells
ranged from 10 to 20% as judged by trypan blue dye
exclusion method. Smears of the alveolar cells
were stained using modified Wright-Giemsa stain
(Diff-Quick, American Scientific Products, U.S.A.).
Based on the percentage of macrophages (based on
differential count) and the total number of live cells,
the total number of macrophages were calculated
and expressed as 104 macrophages per ml of lavage
fluid.
Cytotoxicity assay
HLA-DR positive alveolar macrophages were enu-
merated using antibody and complement mediated
conventional cytotoxicity assay by the method des-
cribed by Whisler and team (13) Briefly, alveolar
cells were incubated for 1 hr at 4°C with 1:100
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final dilution of OK I a1 monoclonal antibody
(Ortho diagnostic systems, Inc. U.S.A) (an anti-
HLA-DR antigen frame work complex expressed
on B-cells, activated T-cells and monocytes). Then
the cell suspension was washed in RPMI -1640
(Rosewall Park Memorial Institute Medium) containing
5% foetal calf serum and was further incubated for
1 hr at 37°C with 1:4 final dilution of rabbit comple-
ment. The percentage of cells susceptible to OK I a1
and complement treatment was assessed using trypan
blue dye exclusion method and expressed as percent
cytotoxicity.
Statistical methods
The results are expressed as arithmetic mean ±
Standard Error (SE). Significance was determined
using the Student’s t-test(14).
Results
The total alveolar macrophage population of the
active tuberculosis, inactive tuberculosis (treated
cases) and non-tuberculous lung disease patients
were significantly higher than the normal individuals
(Fig.) (Normal vs. Active TB=p<0.01; Normal
vs. inactive-TB=p<0.01; Normal vs. Non-TB=
p<0.05). On the other hand, there was no diffe-
Fig. The level of alveolar macrophages in the lavage fluids of various
groups of patients and normal individuals.The four groups
were divided into smokers end non-smokers and the data were
analysed for the macrophage numbers.Mean ± S.E.
rence in their macrophage numbers between the
various groups of patients studied.Since, the indi-
viduals of the normal group were all non-smokers,
the patients were divided into non-smokers and
smokers. Smokers had an increased level of macro-
phage than the non-smoker group. However, the
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active tuberculosis non-smoker group showed almost
an equal level of macrophages when compared to
the active-TB smoker group. Increased number of
alveolar macrophages was observed in the active-TB
non-smoker group than the inactive-TB non-smoker
group and normal individuals. However, there was
no difference in macrophage numbers between non-
smoker group of active-TB and non-TB patients.
A slightly decreased level of macrophage numbers
was seen in the non-smoker group of non-TB patients
than smoker group of the same patient group.
The HLA-DR positive alveolar macrophages were
similar irrespective of the patient groups studied
(smokers + non-smokers).When the patients were
divided into smokers and non-smokers an increased
number of HLA-DR positive alveolar macrophages
was found in smokers than the non-smokers. A
slightly decreased level of -DR positive macro-
phages was observed in non-smoker group of active
tuberculosis patients than the normal subjects. On
the other hand, the HLA-DR positive macrophages
in the non-smoker of inactive-TB and non-TB patient
groups were similar to that of normal subjects (Table).
TABLE
PERCENTAGE HLA-DR POSITIVE ALVEOLAR
MACROPHAGES IN VARIOUS GROUPS OF PATIENTS AND
NORMAL INDIVIDUALS
% Cytotoxicity* Mean ± S.E.
Smokers +
Non-smokers
Non-smokers Smokers
1. Active-TB 46.5 ± 8.5 38.9 ± 11.3 54.7 ± 13.0
(8) (4) (4)
2. Inactive-TB 46.2 ± 3.9 44.4 6.0± 47.7 ± 2.2
(9) (4) (5)
3. Non-TB 59.0 ± 5.7 47.0 65.0 2.6±
(6) (2) (4)
4. Normal – 49.1 5.6± –
(5)
* Percent alveolar macrophages susceptible to Okla1 monoclonal
antibody and rabbit complement.
Numbers in the parantheses represent the number of subjects studied.
Discussion
In the present study, the patient groups (smoker +
non-smoker group) had a higher number of alveolar
macrophages than normal individuals. Further, the
smokers also showed an increased level of total
alveolar macrophages.It is well established that
inflammation due to infection or smoking will lead to
increased number of macrophages. (15).
Among the non-smoker groups studied, patients
with active-TB showed an increased number of
macrophages than normal individuals and patients
with inactive-TB. This suggests that the increased
macrophage population in the non-smoker group of
active-TB could be due to Mycobacterium tuberculosis
infection in the active state of the disease.In the
inactive tuberculosis group, the macrophage popu-
lation was equal to that of normal individuals. These
findings suggest that M. tuberculosis infection in the
lung increases the accumulation of macrophages.
It is well established that smoking or infection due
to any pathogen activates the macrophages (16.17.18)
and enhances the expression of Ia antigens on the
surface and alters other functions of the macro-
phages (9,19,20) Such an increase of Ia positive
cells has been shown in sarcoidosis(21) and other
lung diseases(22).
in the present study, a slightly increased number
of Ia positive (HLA-DR positive) alveolar macro-
phages were seen in the smokers, irrespective of the
patient groups studied.However, non-smokers
showed no difference.In the active TB non-smoker
group, there was a higher macrophage popu-
lation than the inactive-TB patients and normal
individuals; but, slightly reduced level of Ia positive
macrophages were seen in the non-smoker group
of active-TB patients (Table). This could be due
to the bacillary load in the lung, which is probably
not enough to activate the macrophages to express
more HLA-DR antigens. The second possibility is that
the bacilli might have down-regulated the expression
of -DR antigens on the macrophages; it has been
suggested that M. leprae alters the membrane ex-
pression of HLA-DR antigens on the macrophages
of leprosy patients(23). Further, under in vitro
culture conditions, M. microti inhibits the expression
of Ia antigens on the surface of the mouse peritoneal
macrophages(24).
The other explanation for this decrease in DR
positive alveolar macrophages in active TB non-
smoker group is that there are more newly recruited
cells of the monocyte-macrophage lineage which do
not express a detectable level of HLA-DR antigen.
The recent data from our laboratory suggest that an
alveolar macrophage population resistant to OKla1
monoclonal antibody treatment (HLA-DR negative
alveolar macrophages) produced more hydrogen pero-
xide. In a study carried out in the blood monocytes
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of tuberculosis patients, an increased level of Ia
negative monocytes has been shown. The same
study also suggested that HLA-DR negative and
-DR positive phenotypes represent different stages
of maturation(25).
The present study reveals that the increased macro-
phage population is not specific to active pulmonary
tuberculosis. Infection by any pathogen and smo-
king can cause an increase in the macrophage popu-
lation and other cells.It will be useful to study the
role of/these HLA-DR positive and negative alveolar
macrophages in their microbicidal and the immuno-
logical functions to intracellular pathogens such as
M. tuberculosis. Work is progressing in this direction.
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